A multimillion pound investment into global health care company GlaxoSmithKline’s (GSK) Montrose site of was announced today (Friday, November 22).
The £25 million pound expansion of the Montrose site will support the delivery of a new pipeline medicines and will create 25 jobs in the town.
GSk is investing in new state of the art facilities and equipment to bring production of the ingredients for four new pharmaceutical products to Montrose.
President for global manufacturing and supply for GSK made the announcement this morning at the Cobden Street site.
Mr Connor said: “Our teams in Montrose and Irvine are world class and have worked hard to bring new facilities to the two sites. This investment shows how highly we value our teams in Scotland.
“Ours is a fast-moving and competitive environment and the investment should be seen as a vote of confidence in the skills, standards and drive of the people who work here.”
John Swinney, finance secretary, who was at the site today, said: “GSK’s investment is testament to the skill of the Scottish workforce and illustrates the confidence international companies have in Scotland as a country to invest in.
“Montrose has the infrastructure, experience and skills to deliver success for GSK and the company’s commitment to Scotland is further positive news for financial enterprise and the wider Scottish economy.
This investment comes on top of GSK’s pledge last year to invest £100 million in Montrose.
To find out more, see next week’s Review out on Wednesday, November 27.